Additional information
Notes on contributors
Premal H. Thaker
Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.
Matthew P. Smeltzer
Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.
Monique Dawkins
Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.
Leigha Senter-Jamieson
Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.
Stephanie V. Blank
Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.
Destin Black
Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.
Mollie Finkel
Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.
Anna Yemelyanova
Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.
Leigh M. Boehmer
Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.
Sarah Temkin
Premal H. Thaker, MD, MS, is professor at Washington University, Siteman Cancer Center, Saint Louis, Mo. Matthew P. Smeltzer, PhD, is associate professor in the Division of Epidemiology, Biostatistics, and Environmental Health School of Public Health, University of Memphis, Memphis, Tenn. Monique Dawkins, EdD, is assistant director, education, and Leigh M. Boehmer, PharmD, BCOP, is medical director at the Association of Community Cancer Centers, Rockville, Md. Leigha Senter-Jamieson, MS, is associate professor at The Ohio State University, James Cancer Hospital, Comprehensive Cancer Center, Columbus, Ohio. Stephanie V. Blank, MD, is professor and division director of gynecologic oncology, and Mollie Finkel, RN, MSN, is clinal program manager at the Blavatnik Family—Chelsea Medical Center, The Mount Sinai Hospital, New York, N.Y. Destin Black, MD, is director of gynecologic oncology at Willis-Knighton Cancer Center and Louisiana State University Health Shreveport, La. Anna Yemelyanova, MD, is professor of pathology at the Department of Pathology & Laboratory Medicine, Weill Cornell Medicine, New York, N.Y. Sarah Temkin, MD, is a gynecologic oncologist in Washington, D.C.